Magnostics
Magnostics is developing a rapid screening test for Acute Mesenteric Ischemia, which has mortality rate of 60-80%
Status
IP Type
Trade secret
Time
–
Countries
Coverage
A provisional patent application has been submitted with the USPTO and a PCT application will be submitted latter this year.
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 26th of March 2o23
KEEP REVIEWING